Publication

Garcia DO, Lander EM, Wertheim BC, Manson JE, Volpe SL, Chlebowski RT, Stefanick ML, Lessin LS, Kuller LH, Thomson CA. 2016. Pet Ownership and Cancer Risk in the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev. 25:1311–6. doi:10.1158/1055-9965.EPI-16-0218.

Yao M, Woods C, Lavertu P, Fu P, Gibson M, Rezaee R, Zender C, Wasman J, Sharma N, Machtay M, et al. 2016. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head Neck. 38 Suppl 1:E1770–6. doi:10.1002/hed.24313.

Martinez JA, Chalasani P, Thomson CA, Roe D, Altbach M, Galons J-P, Stopeck A, Thompson PA, Villa-Guillen DE, Chow H-HS. 2016. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol. BMC Cancer. 16:500. doi:10.1186/s12885-016-2551-3.

Warfel NA, Sainz AG, Song JH, Kraft AS. 2016. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species. Mol Cancer Ther. 15:1637–47. doi:10.1158/1535-7163.MCT-15-1018.

Patel S, Ragab O, Kamrava M. 2016. Real-time image guidance for gynecologic brachytherapy? Radiother Oncol. 120:542–543. doi:10.1016/j.radonc.2016.03.018.

Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF, Calvert VS, Einspahr J, Dong Z, et al. 2016. Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin. Photochem Photobiol. 92:816–825. doi:10.1111/php.12659.

Ruiz, J. M., Hamann, H. H., O’Connor, M. F., & Mehl, M. (2016). The Hispanic Health Paradox: From Epidemiological Phenomenon to Contribution Opportunities for Psychological Science. Group Processes & Intergroup Relations, 19, 462-476. 2016.

Lance P, Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu C-H, Sherry Chow HH, et al. 2016. Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst. 108. doi:10.1093/jnci/djw152.

Jandova J, Xu W, Nfonsam V. 2016. Sporadic early-onset colon cancer expresses unique molecular features. J Surg Res. 204:251–60. doi:10.1016/j.jss.2016.04.068.

Akam EA, Tomat E. 2016. Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators. Bioconjug Chem. 27:1807–12. doi:10.1021/acs.bioconjchem.6b00332.

Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE. 2016. The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochim Biophys Acta. 1866:221–231. doi:10.1016/j.bbcan.2016.09.005.

Merchant N, Lyons E, Goff S, Vaughn M, Ware D, Micklos D, Antin P. 2016. The iPlant Collaborative: Cyberinfrastructure for Enabling Data to Discovery for the Life Sciences. PLoS Biol. 14:e1002342. doi:10.1371/journal.pbio.1002342.

Kumar GS, Gokhan E, De Munter S, Bollen M, Vagnarelli P, Peti W, Page R. 2016. The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism. Elife. 5. doi:10.7554/eLife.16539.

Cai M, Hruby VJ. 2016. The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases. Curr Protein Pept Sci. 17:488–96. doi:10.2174/1389203717666160226145330.

Khanna A, Lotfi P, Chavan AJ, Montaño NM, Bolourani P, Weeks G, Shen Z, Briggs SP, Pots H, Van Haastert PJM, et al. 2016. The small GTPases Ras and Rap1 bind to and control TORC2 activity. Sci Rep. 6:25823. doi:10.1038/srep25823.

Bhattacharya MRC, Geisler S, Pittman SK, Doan RA, Weihl CC, Milbrandt J, DiAntonio A. 2016. TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance. J Neurosci. 36:4681–9. doi:10.1523/JNEUROSCI.2893-15.2016.

Berman BP, Pandey A, Li Z, Jeffries L, Trouard TP, Oliva I, Cortopassi F, Martin DR, Altbach MI, Bilgin A. 2016. Volumetric MRI of the lungs during forced expiration. Magn Reson Med. 75:2295–302. doi:10.1002/mrm.25798.

Jash A, Wang Y, Weisel FJ, Scharer CD, Boss JM, Shlomchik MJ, Bhattacharya D. 2016. ZBTB32 Restricts the Duration of Memory B Cell Recall Responses. J Immunol. 197:1159–68. doi:10.4049/jimmunol.1600882.

Brown SR, Joshweseoma L, Saboda K, Sanderson P, Ami D, Harris R. 2015. Cancer Screening on the Hopi Reservation: A Model for Success in a Native American Community. J Community Health. 40:1165–72. doi:10.1007/s10900-015-0043-z.

Romagnolo DF, Papoutsis AJ, Laukaitis C, Selmin OI. 2015. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis. BMC Cancer. 15:1026. doi:10.1186/s12885-015-2044-9.

Vedantham S, Karellas A, Vijayaraghavan GR, Kopans DB. 2015. Digital Breast Tomosynthesis: State of the Art. Radiology. 277(3):663–684. doi:10.1148/radiol.2015141303.

Davis R, Loescher LJ, Rogers J, Spartonos D, Snyder A, Koch S, Harris RB. 2015. Evaluation of Project Students are Sun Safe (SASS): A University Student-Delivered Skin Cancer Prevention Program for Schools. J Cancer Educ. 30:736–42. doi:10.1007/s13187-014-0742-7.

Dodds SE, Pace TWW, Bell ML, Fiero M, Negi LT, Raison CL, Weihs KL. 2015. Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors: a randomized, wait list controlled pilot study. Support Care Cancer. 23:3599–608. doi:10.1007/s00520-015-2888-1.

Singh N, Joshi S, Guo L, Baker MB, Li Y, Castellano RK, Raizada MK, Jarajapu YPR. 2015. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells. Am J Physiol Heart Circ Physiol. 309:H1697–707. doi:10.1152/ajpheart.00854.2014.

Stanton AL, Wiley JF, Krull JL, Crespi CM, Hammen C, Allen JJB, Barrón ML, Jorge A, Weihs KL. 2015. Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat. 154:105–15. doi:10.1007/s10549-015-3563-4.